- Home
- VNDA vs NOTE Comparison
VNDA vs NOTE Comparison
Compare VNDA & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- NOTE
- Stock Information
- Founded
- VNDA 2002
- NOTE 2013
- Country
- VNDA United States
- NOTE United States
- Employees
- VNDA N/A
- NOTE N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- NOTE EDP Services
- Sector
- VNDA Health Care
- NOTE Technology
- Exchange
- VNDA Nasdaq
- NOTE Nasdaq
- Market Cap
- VNDA 237.9M
- NOTE N/A
- IPO Year
- VNDA 2006
- NOTE N/A
- Fundamental
- Price
- VNDA $4.22
- NOTE $0.64
- Analyst Decision
- VNDA Strong Buy
- NOTE Strong Buy
- Analyst Count
- VNDA 2
- NOTE 7
- Target Price
- VNDA $16.50
- NOTE $2.76
- AVG Volume (30 Days)
- VNDA 500.0K
- NOTE 1.2M
- Earning Date
- VNDA 05-07-2025
- NOTE 05-12-2025
- Dividend Yield
- VNDA N/A
- NOTE N/A
- EPS Growth
- VNDA N/A
- NOTE N/A
- EPS
- VNDA N/A
- NOTE 0.07
- Revenue
- VNDA $201,351,000.00
- NOTE $120,266,000.00
- Revenue This Year
- VNDA $14.36
- NOTE N/A
- Revenue Next Year
- VNDA $44.53
- NOTE $42.32
- P/E Ratio
- VNDA N/A
- NOTE $9.28
- Revenue Growth
- VNDA 13.37
- NOTE N/A
- 52 Week Low
- VNDA $3.85
- NOTE $0.56
- 52 Week High
- VNDA $6.75
- NOTE $2.07
- Technical
- Relative Strength Index (RSI)
- VNDA 41.17
- NOTE 41.15
- Support Level
- VNDA $4.20
- NOTE $0.60
- Resistance Level
- VNDA $4.64
- NOTE $0.67
- Average True Range (ATR)
- VNDA 0.17
- NOTE 0.05
- MACD
- VNDA 0.01
- NOTE 0.02
- Stochastic Oscillator
- VNDA 20.75
- NOTE 65.99
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.